RAVI KOTHAPALLI
Medical Practice at Birds Eye Dr, Zephyrhills, FL
License number
Florida 42674
Issued Date
Nov 19, 2009
Effective Date
Nov 19, 2009
Expiration Date
Aug 31, 2018
Category
Health Care
Type
Clinical Laboratory Personnel
Address
Address
2
29623 Birds Eye Dr, Zephyrhills, FL 33543
10902 N.mckinley Dr N.McKinley, Tampa, FL 33612
10902 N.mckinley Dr N.McKinley, Tampa, FL 33612
Phone
(813) 907-7346
Professional information
Ravi Kothapalli
Specialties:
Buyer's Agent, Listing Agent
Work:
3450 Buschwood Park Dr, Tampa 33618
Ravi Kothapalli, Tampa FL
Work:
La Rosa Realty
Tampa
(813) 317-6979
Tampa
(813) 317-6979
Method For The Diagnosis Of Selected Adenocarcinomas
US Patent:
5916751, Jun 29, 1999
Filed:
Aug 27, 1997
Appl. No.:
8/919421
Inventors:
Siamak Tabibzadeh - Tampa FL
Ravi Kothapalli - Tampa FL
Ravi Kothapalli - Tampa FL
Assignee:
University of South Florida - Tampa FL
International Classification:
G01N 33574, G01N 3348, C12Q 168
US Classification:
435 6
Abstract:
A method for the early diagnosing of selected adenocarcinomas in a human comprising the steps of removing a bodily sample from the human, and assaying the bodily sample for elevated expression of a specific gene, the gene being assayed for in the bodily sample is the TGFB-4 gene (hereinafter referred to as the endometrial bleeding associated factor (ebaf) gene. The bodily sample can be tissue from a specific organ in the body, or a blood sample. Increased levels of ebaf in the sample relative to basal levels may be indicative of a mucinous adenocarcinoma of the colon or ovaries, or an adenocarcinoma of the testis.
Method For Diagnosing Selected Adenocarcinomas
US Patent:
7705131, Apr 27, 2010
Filed:
Jan 17, 2007
Appl. No.:
11/654074
Inventors:
Siamak Tabibzadeh - Albertson NY, US
Ravi Kothapalli - Wesley Chapel FL, US
Ravi Kothapalli - Wesley Chapel FL, US
Assignee:
University of South Florida - Tampa FL
International Classification:
C07K 16/00
US Classification:
5303871
Abstract:
A method for the early diagnosing of selected adenocarcinomas in a human comprising the steps of removing a bodily sample from the human, and assaying the bodily sample for elevated expression of a specific gene. The gene being assayed for in the bodily sample is the TGFB-4 gene (hereinafter referred to as the endometrial bleeding associated factor (ebaf) gene. The bodily sample can be tissue from a specific organ in the body, or a blood sample. Increased levels of ebaf in the sample relative to basal levels may be indicative of a mucinous adenocarcinoma of the colon or ovaries, or an adenocarcinoma of the testis.
Method For Diagnosing Selected Adenocarcinomas
US Patent:
RE41007, Nov 24, 2009
Filed:
May 9, 2007
Appl. No.:
11/801428
Inventors:
Siamak Tabibzadeh - Albertson NY, US
Ravi Kothapalli - Wesley Chapel FL, US
Ravi Kothapalli - Wesley Chapel FL, US
Assignee:
University of South Florida - Tampa FL
International Classification:
C07H 21/04
US Classification:
536 235
Abstract:
A method for the early diagnosing of selected adenocarcinomas in a human comprising the steps of removing a bodily sample from the human, and assaying the bodily sample for elevated expression of a specific gene. The gene being assayed for in the, bodily sample is the TGFB-4 gene (hereinafter referred to as the endometrial bleeding associated factor (ebaf) gene. The bodily sample can be tissue from a specific organ in the body, or a blood sample. Increased levels of ebaf in the sample relative to basal levels may be indicative of a mucinous adenocarcinoma of the colon or ovaries, or an adenocarcinoma of the testis.
Nucleic Acids Encoding An Endometrial Bleeding Associated Factor (Ebaf)
US Patent:
RE40937, Oct 13, 2009
Filed:
May 9, 2007
Appl. No.:
11/801427
Inventors:
Siamak Tabibzadeh - Albertson NY, US
Ravi Kothapalli - Wesley Chapel FL, US
Ravi Kothapalli - Wesley Chapel FL, US
Assignee:
University of South Florida - Tampa FL
International Classification:
C07H 21/02, C07H 21/04
US Classification:
536 235, 536 231, 536 2431
Abstract:
A method for the early diagnosing of selected adenocarcinomas in a human comprising the steps of removing a bodily sample from the human, and assaying the bodily sample for elevated expression of a specific gene. The gene being assayed for in the bodily sample is the TGFB-4 gene (hereinafter referred to as the endometrial bleeding associated factor (ebaf) gene. The bodily sample can be tissue from a specific organ in the body, or a blood sample. Increased levels of ebaf in the sample relative to basal levels may be indicative of a mucinous adenocarcinoma of the colon or ovaries, or an adenocarcinoma of the testis.
Sphingosine 1-Phosphate Receptor Gene, Sppr
US Patent:
7964358, Jun 21, 2011
Filed:
Sep 10, 2010
Appl. No.:
12/879918
Inventors:
Thomas P. Loughran - Hummelstown PA, US
Ravi Kothapalli - Wesley Chapel FL, US
Ravi Kothapalli - Wesley Chapel FL, US
Assignee:
University of South Florida - Tampa FL
International Classification:
C12Q 1/68, G01N 33/53
US Classification:
435 6, 435 71
Abstract:
A novel sphingosine 1-phosphate receptor gene, herein termed sppr, and its splice variants. Sppr is up-regulated in LGL and is useful, for example, in the diagnosis and treatment of certain lymphoproliferative, neurodegenerative and autoimmune diseases.
Sphingosine 1-Phosphate Receptor Gene, Sppr
US Patent:
2007010, May 10, 2007
Filed:
Jan 16, 2007
Appl. No.:
11/653811
Inventors:
Thomas Loughran - Lutz FL, US
Ravi Kothapalli - Wesley Chapel FL, US
Ravi Kothapalli - Wesley Chapel FL, US
International Classification:
C12Q 1/68, G01N 33/567, C12P 21/06, C07K 14/705, C07K 16/28
US Classification:
435006000, 435007200, 530350000, 435069100, 435320100, 435325000, 530388220
Abstract:
A novel sphingosine 1-phosphate receptor gene, herein termed sppr, and its splice variants. Sppr is up-regulated in LGL and is useful, for example, in the diagnosis and treatment of certain lymphoproliferative, neurodegenerative and autoimmune diseases.
Sphingosine 1-Phosphate Receptor Gene, Sppr
US Patent:
2009018, Jul 16, 2009
Filed:
Aug 18, 2008
Appl. No.:
12/193428
Inventors:
Ravi Kothapalli - Wesley Chapel FL, US
International Classification:
C12Q 1/68, C12N 5/10, C12P 21/00
US Classification:
435 6, 435325, 435 691
Abstract:
A novel sphingosine 1-phosphate receptor gene, herein termed sppr, and its splice variants. Sppr is up-regulated in LGL and is useful, for example, in the diagnosis and treatment of certain lymphoproliferative, neurodegenerative and autoimmune diseases.
Sphingosine 1-Phosphate Receptor Gene, Sppr
US Patent:
7220580, May 22, 2007
Filed:
Dec 21, 2001
Appl. No.:
10/024019
Inventors:
Ravi Kothapalli - Wesley Chapel FL, US
Assignee:
University of South Florida - Tampa FL
International Classification:
C12N 5/10, C12N 15/12, C12N 15/63, C12N 1/21, C12Q 1/68
US Classification:
435325, 435 6, 435 691, 4352523, 4353201, 530350, 536 235
Abstract:
A novel sphingosine 1-phosphate receptor gene, herein termed sppr, and its splice variants. Sppr is up-regulated in LGL and is useful, for example, in the diagnosis and treatment of certain lymphoproliferative, neurodegenerative and autoimmune diseases.